Campylobacter fetus bacteraemia in a healthy individual: clinical and therapeutical implications.

Campylobacter fetus bacteraemia in a healthy individual: clinical and therapeutical implications. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Campylobacter fetus bacteraemia in a healthy individual: clinical and therapeutical implications. Abstract Text:

Dimitrios I Zonios,Georgios D Panayiotakopoulos,Eleytherios O Kabletsas,Eystathia L Tzima,Ioanna Stefanou,Athanasios J Archimandritis,

Campylobacter species are well-recognized common causes of gastrointestinal infections. While Campylobacter jejuni is probably the most common Campylobacter isolated in humans, Campylobacter fetus is rather infrequent and mostly related with bacteraemia. Even on such occasions, it seems that immunocompetent individuals are spared. We report a case of C. fetus bacteraemia in a healthy-except for impaired fasting glucose (IFG) levels-farmer, presenting as an acute febrile syndrome and treated successfully as brucellosis.

Campylobacter fetus bacteraemia in a healthy individual: clinical and therapeutical implications. Publishing Authors By Initials

DI Zonios,GD Panayiotakopoulos,EO Kabletsas,EL Tzima,I Stefanou,AJ Archimandritis,

For similar biological phenomena, cell phenomena, and immunity: biological phenomena: microbiologic phenomena: virulence research abstracts see: biological phenomena, cell phenomena, and immunity: biological phenomena: microbiologic phenomena: virulence research

PUBMED ID PMID:

MEDLINE DATE:

Campylobacter fetus bacteraemia in a healthy individual: clinical and therapeutical implications. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: The Journal of infection

VOLUME: 51

Page Numbers: 329-32

Journal Abbreviation: J. Infect.

ISSN: 1532-2742

DAY: 14

MONTH: Nov

YEAR: 2005

Campylobacter fetus bacteraemia in a healthy individual: clinical and therapeutical implications. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7908424

Campylobacter fetus bacteraemia in a healthy individual: clinical and therapeutical implications. Keywords Mesh Terms:

KEYWORDS: Virulence

MESH TERMS: analysis

Chemical & Substance for Abstract: Campylobacter fetus bacteraemia in a healthy individual: clinical and therapeutical implications. Information

Substance Name: Glucose

Registry Number: 50-99-7

Grant and Affiliation Information for Campylobacter fetus bacteraemia in a healthy individual: clinical and therapeutical implications.

AFFILIATION: Department of Pathophysiology, Medical School, University of Athens, 75 Mikras Asias Street, Athens 115 27, Greece. dzonios@otenet.gr

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Infect

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Campylobacter fetus bacteraemia in a healthy individual: clinical and therapeutical implications Related Publications

• A 70-year-old stock-breeder with tricuspid valve and defibrillator lead brucella endocarditis.
• Adipokines and insulin resistance in chronic hepatitis C.
• Amanita phalloides poisoning: reassessment of prognostic factors and indications for emergency liver transplantation.
• An extranodal NK/T cell lymphoma, nasal type, with specific immunophenotypic and genotypic features.
• Angioimmunoblastic T-cell lymphoma-associated arthritis: case report and literature review.
• Campylobacter fetus bacteraemia in a healthy individual: clinical and therapeutical implications.
• Changes of liver and muscle enzymes activity in patients with rigor.
• Epidemiological evidence for the non-random clustering of the components of the metabolic syndrome: multicentre study of the Mediterranean Group for the Study of Diabetes.
• Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C.
• Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
• Myelodysplastic syndrome presenting as acquired ichthyosis.
• Performance Characteristics of Microparticle Enzyme and Chemiluminescence Immunoassays for Measurement of Anti-HBc Immunoglobulin M in Sera of Patients with HBeAg-Negative Chronic Hepatitis B Virus Infection.
• Pseudohyperkalemia in serum: a new insight into an old phenomenon.
• Sensorineural hearing loss complicating severe rickettsial diseases: report of two cases.
• Serum adipokine levels in chronic liver diseases: Association of resistin levels with fibrosis severity.
• Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
• Severe rhabdomyolysis with hypoglycemia in an adult patient with carnitine palmitoyltransferase II deficiency.
• Systemic Vasculitis With Gastrointestinal Involvement in an HIV-Infected Adult.
• Therapeutic strategies in the management of patients with chronic hepatitis B virus infection.
• Usefulness of enzyme-linked immunosorbent assay (elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. Addendum.
• Usefulness of enzyme-linked immunospot assay (elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment.